Literature DB >> 3026309

Thyroliberin action in pituitary cells is not inhibited by pertussis toxin.

P M Hinkle, E L Hewlett, M C Gershengorn.   

Abstract

The effects of pertussis toxin on the responses of rat pituitary-tumour (GH) cells to thyrotropin-releasing hormone (thyroliberin, TRH) were examined. Treatment of cells with pertussis toxin did not alter the affinity or concentration of TRH receptors, or the sensitivity of the TRH receptor to inhibition by guanine nucleotides. TRH caused an increase in low-Km GTPase activity in membrane-containing fractions from both control and pertussis-toxin-treated cells. TRH stimulation of inositol phosphate formation was insensitive to pertussis toxin. TRH caused a biphasic increase in the concentrations of cytosolic free Ca2+ as monitored by intracellularly trapped Quin 2, and this increase was the same in control and toxin-treated cultures. The toxin did not alter the increase in prolactin and growth-hormone (somatotropin) release stimulated by TRH or shift the TRH dose-response curve, and it did not affect the TRH-induced rise in prolactin synthesis measured over 24 h. However, pertussis toxin did block the ability of somatostatin and muscarinic agonists to inhibit prolactin and growth-hormone secretion stimulated by vasoactive intestinal peptide when analysed under the same conditions as those in which the TRH system was unaffected. These data indicate that the guanine nucleotide effects on TRH binding and activity are not mediated by Ni, but possibly by another member of the family of guanine-nucleotide-dependent regulatory proteins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3026309      PMCID: PMC1146963          DOI: 10.1042/bj2370181

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Receptors for thyrotropin-releasing hormone in prolactin producing rat pituitary cells in culture.

Authors:  P M Hinkle; A H Tashjian
Journal:  J Biol Chem       Date:  1973-09-10       Impact factor: 5.157

3.  Thyrotropin-releasing hormone stimulates rapid loss of phosphatidylinositol and its conversion to 1,2-diacylglycerol and phosphatidic acid in rat mammotropic pituitary cells. Association with calcium mobilization and prolactin secretion.

Authors:  M J Rebecchi; R N Kolesnick; M C Gershengorn
Journal:  J Biol Chem       Date:  1983-01-10       Impact factor: 5.157

4.  Calcium influx is not required for TRH to elevate free cytoplasmic calcium in GH3 cells.

Authors:  M C Gershengorn; C Thaw
Journal:  Endocrinology       Date:  1983-10       Impact factor: 4.736

5.  Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands.

Authors:  M J Berridge; C P Downes; M R Hanley
Journal:  Biochem J       Date:  1982-09-15       Impact factor: 3.857

6.  Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator.

Authors:  R Y Tsien; T Pozzan; T J Rink
Journal:  J Cell Biol       Date:  1982-08       Impact factor: 10.539

7.  Involvement of guanine nucleotide-binding protein in the gating of Ca2+ by receptors.

Authors:  B D Gomperts
Journal:  Nature       Date:  1983 Nov 3-9       Impact factor: 49.962

8.  Catecholamine-stimulated GTPase activity in turkey erythrocyte membranes.

Authors:  D Cassel; Z Selinger
Journal:  Biochim Biophys Acta       Date:  1976-12-08

9.  The polyphosphoinositide phosphodiesterase of erythrocyte membranes.

Authors:  C P Downes; R H Michell
Journal:  Biochem J       Date:  1981-07-15       Impact factor: 3.857

10.  Regulation of Ca2+-dependent cyclic AMP accumulation and Ca2+ metabolism in intact pituitary tumor cells by modulators of prolactin production.

Authors:  M A Brostrom; C O Brostrom; L A Brotman; S S Green
Journal:  Mol Pharmacol       Date:  1983-03       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.